OXFORD ENDOVASCULAR LIMITEDActive
Key figures
OXFORD ENDOVASCULAR LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Profit for the year | -2,137,992 | -1,932,120 | -2,352,991 | -2,936,320 | -2,564,310 |
| Cash at bank and in hand | 7,819,321 | 5,293,612 | 2,798,953 | 7,923,920 | 5,162,662 |
| Total assets | 8,407,601 | 5,880,437 | 3,636,445 | 8,460,397 | 5,857,943 |
| Total liabilities | 2,051,089 | 1,151,641 | 956,138 | 794,716 | 584,303 |
| Net assets / total equity | 6,356,512 | 4,728,796 | 2,680,307 | 7,665,681 | 5,273,640 |
| Average number of employees | 7 | 7 | 7 | 6 | 9 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: OXFORD ENDOVASCULAR LIMITED
Company
OXFORD ENDOVASCULAR LIMITED is a private limited company registered with Companies House under company number 09769779. It was incorporated on 9 Sep 2015. Its status is active. The registered office is in Oxford (OX4). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Loss for the year was £2,564,310. Net assets were £5,273,640, down 31.2% on the previous year. Cash at bank and in hand was £5,162,662. Total assets were £5,857,943 and total liabilities £584,303. The company had an average of 9 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 23 Sep 2027.